Open

Device Testing Study for Adults with Depression

The purpose of this study is to test a brain stimulation device in Adults with Depression. We aim to make sure the device functions as designed and appropriately stores and transmits data.

Age & Gender

18 years ~ 70 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Extended hours (M-F, early morning or evening)

Location

North Carolina (Statewide)

What will be asked of you

This study includes 1 online prescreening survey taking abut 3-5 minutes, 1 virtual screening session taking about 1 hour, and 1 in-person session at which you will receive up to 40 minutes of noninvasive brain stimulation and answer survey questions.

Incentives

$100 upon completion of the stimulation session.

In-person visits:
1

Phone or online visits:
1

Total length of participation:
2 hours 30 minutes

Looking for Specific Volunteers

Able to participate:

Between the ages of 18-70
Have a diagnosis of Major Depressive Disorder

Not eligible if:

Have a diagnosis of Bipolar Disorder, Schizophrenia, psychotic disorder or autism
History of seizure
Have a neurological disorder such as dementia, history of stroke, Parkinson's Disease, Multiple Sclerosis, history of traumatic brain injury, ruptured cerebral aneurysm
Have had prior brain surgery and/or brain implants or have any implanted medical device that uses electricity
Currently pregnant or breastfeeding

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Visit Study Website

Primary Visit Location

Carolina Center for Neurostimulation
100 Market Street, Chapel Hill, NC, USA

Additional Study Information

Principal Investigator

David Rubinow
Psychiatry - Research

Study Type

Clinical or Medical
Interventional

Study Topics

Mental and Emotional Health

IRB Number

24-0712

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.